Cite

HARVARD Citation

    Halmos, B. et al. (2015). Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib‐Responsive Non‐Small Cell Lung Cancer. Oncologist. pp. 1298-1303. [Online]. 
  
Back to record